A recent review article highlights evolving MS-based methodologies that are reshaping ligand discovery and mechanistic characterization for membrane protein drug targets. LCGC International spoke to ...

Metabolic dysfunction-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease (NAFLD), affects over 30% of the global adult population. Characterized by at least 5% ...

MO’Donnell flayed "madman" Trump over a cabinet meeting rant that drew laughter from the people who wield the 25th Amendment power to remove him.

The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...

Diagnosed with multiple sclerosis in 2010, blind skier and three-time bronze medal winner Danelle Umstead went on to compete ...

A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS ...

Running became my training ground not only for fitness but for sobriety itself. As the miles added up, so did the challenges: ...

Authorities seized nearly two pounds of fentanyl and over 15,000 pressed pills in the Gulfport drug house. Here’s more: ...

Ultra-rare disorders are those affecting fewer than one person in 50,000. Sometimes, indeed, they are unique. And unique problems demand unique solutions. To that end Ms Vitarello created Mila’s ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight.

They argued long-term medication was a necessary medical treatment for OUD, just as insulin is for type 1 diabetes. Drawing on Dole's background in endocrinology and metabolism, the researchers ...